Brain Targeted Xenon Protects Cerebral Vasculature After Traumatic Brain Injury
Journal of Neurotrauma · 2023
DOI: 10.1089/neu.2022.0468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurotrauma, 2023. Verfasst von Samuel S Shin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurocritical Care, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, U…. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Brain Injuries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Cerebrovascular dysfunction following traumatic brain injury (TBI) is a well-characterized phenomenon. Given the therapeutic potential of xenon, we aimed to study its effects after localized delivery to the brain using microbubbles. We designed xenon-containing microbubbles stabilized by dibehenoylphosphatidylcholine (DBPC) and polyethylene glycol (PEG) attached to saturated phospholipid (DPSE-PEG5000). Using a pig model of TBI, these microbubbles were intravenously injected, and ultrasound was used to release xenon at the level of the carotid artery. The control group received perfluorobutane containing microbubbles. Diffusion tensor imaging (DTI) showed areas of higher fractional anisotropy for pigs receiving xenon microbubbles compared to the control group at 1 day after injury. Radial diffusivity analysis showed that this effect was mainly the result of acute edema. Pigs were euthanized at 5 days, and the brain tissues of xenon-treated animals showed reduction of perivascular inflammation and blood–brain barrier disruption. Endothelial cell culture experiments showed that glutamate reduces tight junction protein zona occludens-1 (ZO-1), but treatment with xenon microbubbles attenuates this effect. Xenon treatment protects cerebrovasculature and reduces astroglial reactivity after TBI. Further, these data support the future use of localized delivery of various therapeutic agents for brain injury using microbubbles in order to limit systemic side effects and reduce costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurocritical Care, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Shin, S. S., Chattaraj, R., Viaene, A. N., Karmacharya, M. B., Haddad, S., Degani, R., Sridharan, A., Sehgal, C., Lee, D., Kilbaugh, T. J., & Hwang, M. (2023). Brain Targeted Xenon Protects Cerebral Vasculature After Traumatic Brain Injury. Journal of Neurotrauma. https://doi.org/10.1089/neu.2022.0468
Vancouver
Shin SS, Chattaraj R, Viaene AN, Karmacharya MB, Haddad S, Degani R, et al. Brain Targeted Xenon Protects Cerebral Vasculature After Traumatic Brain Injury. Journal of Neurotrauma. 2023. doi:10.1089/neu.2022.0468
BibTeX
@article{Shin2023,
author = {Shin, Samuel S and Chattaraj, Rajarshi and Viaene, Angela N and Karmacharya, Mrigendra B and Haddad, Sophie and Degani, Rinat and Sridharan, Anush and Sehgal, Chandra and Lee, Daeyeon and Kilbaugh, Todd J and Hwang, Misun},
title = {Brain Targeted Xenon Protects Cerebral Vasculature After Traumatic Brain Injury},
journal = {Journal of Neurotrauma},
year = {2023},
doi = {10.1089/neu.2022.0468}
}
EUVIMED